Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • GerryB
    Member
    • May 2009
    • 12

    #1

    Alignment/assembly programs - Patent minefield

    There are many programs to align short reads to a reference, and quite a few denovo assemblers as well. The terrific list here gives great links to many tools.

    But when I see these nifty toys and pick them up to examine them, it's clear that there's a quietly deadly dangers in many, in fact probably all, of the tools.

    Which of these tools are safe to use without fear of patent violations? From my experience in database tools, the patent mindfield is terrible. But it seems even worse in bioinformatics because the field is newer and therefore more of the basic infrastructure has been patented from the start.



    The Celera assembler for example, is covered by multiple patents and it's clearly not legal to use their methods, even for academic non-profit use. The GPL license is not what I'm talking about, but the patents underlaying its function. I'm not saying people haven't used the assember, but that their use is likely a violation even if Celera hasn't persued it yet. Celera is also far from the only patent holder.

    This applies to almost all of these tools. I doubt any one of them is free from patent restrictions. Even the awesome and elegant Bowtie is likely infringing multiple times, since about anything that uses the BWT to search on DNA sequences is patented.

    How are people protecting themselves from this issue? Have patent holders like Celera offered licenses, or indemity, at least for noncommercial users?
    How do the researchers of these algorithms defend themselves?

    How could any company even think to commercialize such tools unless they have a huge portfolio of patents of their own to play mutual-assured-destruction faceoffs with?

    I fear that the answers to these questions is that people have just ignored the issues for now and hope that none of the patent holders decides to start poking at their projects.
  • jkbonfield
    Senior Member
    • Jul 2008
    • 146

    #2
    There's no doubt that this is a mine field, however the BWT based aligners could argue they're based primarily on the fm-index papers (which predate these patents) rather than the specific tweaks employed in these patents.

    A complex mess though, and one which only serves to demonstrate why software patents are generally bad for science as a whole.

    Comment

    • lry198010
      Member
      • Aug 2008
      • 13

      #3
      I think it's really the issue when the analysis tool such as BWT are necessary in the personal genome era.

      Comment

      • mchaisso
        Member
        • Apr 2008
        • 84

        #4
        IANAL, but unless one has a method that is not based on published papers, a better business model may be the service model, rather than patent and protect.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 10:13 AM
        0 responses
        14 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        29 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        22 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Working...